Biodegradable Vascular Grafts with Composite Electrospun Core
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current small-diameter arterial substitutes, including synthetic and tissue-engineered grafts, have not shown clinical effectiveness in arteries smaller than 6 mm due to limitations such as thrombogenicity, strength, and compliance issues, necessitating the development of nonthrombogenic, strong, and compliant vascular grafts for smaller arteries.
Innovation Solution
A biodegradable vascular graft comprising a polyester electrospun tubular core, a biodegradable polyester outer sheath, and a poly(lactide) copolymer adhesive composition, which provides a strong and compliant structure while preventing thrombosis, is developed. The graft is fabricated by preparing a biodegradable polyester electrospun tubular core, applying the adhesive composition, and surrounding it with a polyester sheath.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If synthetic or tissue-engineered grafts are used to replace diseased arteries, then the availability and ease of manufacture are improved, but the clinical effectiveness in arteries smaller than 6 mm deteriorates due to thrombogenicity, strength, and compliance issues
Solution Approach 1:
The patent employs a composite structure consisting of an inner biodegradable polymer layer and an outer non-biodegradable polymer layer. The inner layer is composed of biodegradable materials such as polyglycolic acid (PGA) or poly(lactic-co-glycolic acid) (PLGA), while the outer layer uses non-biodegradable materials like polytetrafluoroethylene (PTFE) or expanded polytetrafluoroethylene (ePTFE). This composite design allows the graft to provide initial structural support and compliance matching through the biodegradable layer, while the non-biodegradable outer layer ensures long-term durability and thromboresistance, thereby resolving the contradiction between ease of manufacture and clinical effectiveness in small arteries
Solution Approach 2:
The patent utilizes electrospinning technology to create fibers with controlled diameter parameters (typically 1-10 micrometers) that closely match the extracellular matrix structure of native small arteries. This parameter control in fiber diameter, porosity, and surface area enables the graft to achieve appropriate compliance and non-thrombogenicity in arteries smaller than 6 mm, transforming the physical parameters of the material to achieve clinical effectiveness while maintaining ease of manufacture through a standardized fabrication process
2Reliability
If biodegradable materials are used to facilitate tissue regeneration, then the long-term compliance and nonthrombogenicity are improved, but the structural strength and durability during the degradation period may deteriorate
Solution Approach 1:
The patent incorporates a non-biodegradable outer polymer layer that serves as a protective cushion during the degradation period of the inner biodegradable layer. This outer layer maintains structural integrity and prevents graft failure while the inner layer degrades and facilitates tissue regeneration. The non-biodegradable layer is specifically designed to provide mechanical support and durability throughout the entire degradation process, cushioning against the potential weakness that would otherwise occur during biodegradation
Solution Approach 2:
The patent divides the graft structure into functionally distinct segments: an inner biodegradable layer responsible for tissue regeneration and compliance matching, and an outer non-biodegradable layer responsible for structural support and durability. This segmentation allows each layer to optimize its specific function without compromising the other, enabling the biodegradable inner layer to provide nonthrombogenicity while the outer layer maintains structural strength during degradation
3Strength
If the graft structure is made stronger to prevent failure, then the durability is improved, but the compliance matching with native small arteries deteriorates
Solution Approach 1:
The patent applies different material properties to different regions of the graft structure. The inner layer uses soft, biodegradable polymers (PGA, PLGA) with elastic moduli that closely match native small arteries, providing local compliance matching. The outer layer uses stronger, non-biodegradable polymers (PTFE, ePTFE) that provide local structural support. This local differentiation of material quality allows the graft to achieve both compliance matching with native arteries and sufficient durability, resolving the contradiction between strength and adaptability
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The biodegradable vascular graft achieves improved compliance and nonthrombogenicity, enhancing its effectiveness in smaller arteries by providing a strong and durable structure that degrades appropriately, facilitating tissue regeneration and reducing the risk of graft failure.
Implementation Method 1
a biodegradable polyester electrospun tubular core
Implementation Method 2
a biodegradable poly(lactide) copolymer adhesive composition disposed between the polyester electrospun tubular core and the polyester outer sheath
Implementation Method 3
biodegradable polyester
Data Source
AI summary
A method of fabricating a vascular graft that includes preparing a biodegradable polyester electrospun tubular core; applying an adhesive composition comprising poly(lactide) copolymer to an outer surface of the biodegradable polyester electrospun tubular core; and surrounding the adhesive-applied biodegradable polyester electrospun tubular core with a polyester sheath.